Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells (UCPOGC) is a rare, highly malignant pancreatic exocrine neoplasm. Here, we report a case of UCPOGC in a 58-year-old man who presented with abdominal pain and weight loss. Abdomen computed tomography (CT) revealed a 5cm sized pancreatic body mass with peripheral enhancement. Endoscopic ultrasound (EUS)-guided biopsy of the mass suggested a solid-pseudopapillary tumor of the pancreas with a marked degenerative change. Distal pancreatectomy and splenectomy were performed. The size of the mass was 5.4 × 4.8 cm and the cut surface showed necrosis and hemorrhage. A definite diagnosis of UCPOGC was made using the histopathology and immunohistochemical findings. Korean J Pancreas Biliary Tract 2016;21(3):144-149 Keywords: Carcinoma, Undifferentiated, Osteoclast, Giant cells, Pancreas No allergies or any significant family history was noted. On physical examination, he appeared to be chronically ill, with soft, non-tender abdomen. Vital signs were within normal range.
INTRODUCTION
Undifferentiated carcinoma of the pancreas with osteoclastlike giant cells (UCPOGC), first described by Juan Rosai in 1968, is a rare, highly malignant exocrine tumor. 1 UCPOGC is now classified by the World Health Organization as a rare variant of ductal adenocarcinoma, based on the epithelial origin of this tumor. In the early reports on this tumor it was suggested that they may have a more favorable prognosis compared with the usual ductal adenocarcinoma. 2, 3 UCPOGC tends to present at the mean age of 60 years, and has the same sex distribution. Microscopic findings consist of atypical mononuclear round cells and abundant osteoclast-like multinucleated giant cells, thus, mimicking a giant cell tumor of the bone. 2 Here, we report a case of UCPOGC and describe its characteristics.
CASE
A 58-year-old man visited our outpatient clinic due to left Immunohistochemical stain showed cells positive for alpha-1-antitrypsin, vimentin, CD10 and beta-catenin, and negative The main signs and symptoms are abdominal pain, weight loss, fatigue, anorexia, and palpable mass. The CT scan shows irregular cystic and solid tumor with heterogeneous enhancement by the contrast. 5 MRI findings of this tumor have not been established yet. Hur et al. 6 reported UCPOGC with low signal intensity on T1-weighted image and heterogeneous high signal intensity with multifocal cystic lesions on T2-weighted image. Other case reported heterogeneous high signal intensity within the mass on T1-weighted image that was thought to be a cystic hemorrhage. 7 Another case showed low signal intensity on T2-weighted image. 8 The explanation for these findings is not clear, but we hypothesize that various extents of hemorrhage and necrosis of this tumor contribute to diverse MRI findings. In present case, the mass showed low signal intensity on both T1-and T2-weighted MRI.
Tumor markers, CEA and CA 19-9 are less commonly elevated and not distinct. The diagnosis is usually made on surgical specimen. In some cases, EUS-FNA has shown to be effective, and an accurate diagnosis had been achieved by cytology test. 2, 9 UCPOGC is classified by the World Health Organization ant cells is the histological hallmark of UCPOGC, we were confident to definitely conclude UCPOGC as a diagnosis. 6 The prognosis of UCPOGC is poor, but it is better than that of the usual ductal adenocarcinoma. Lung and liver metastasis were commonly reported. Peritoneum, bone, prostate and adrenal metastasis were also reported. 12, 13 But, there is no report of soft tissue metastasis in UCPOGC patients until now. In our case, soft tissue metasta- It is difficult to determine an optimal treatment modality for this tumor due to its rarity. Therefore, early diagnosis and complete resection could be only chance to cure this tumor.
When irregular solid and cystic pancreatic mass observed on imaging test, as it did in our case, UCPOGC should be considered in the differential diagnosis.
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